Amgen Inc. (AMGN) Q4 2015 Earnings Results

Amgen Beats on EPS, Stock Down 1.4%

Amgen's earnings report showed a strong EPS performance, beating expectations by over 15%. However, the stock reacted negatively, declining by 1.4%. The lack of revenue figures and guidance may have contributed to investor uncertainty, overshadowing the positive EPS surprise.

The print

Key numbers

Actual vs. consensus

Metric	Actual	Expected	Surprise
EPS	$2.61	N/A	+15.03%
Revenue	N/A	N/A	N/A

Management

Management commentary

Tone: Cautiously Optimistic

Overall, management conveyed a sense of cautious optimism regarding the company's future prospects. They highlighted the importance of their ongoing projects and the potential for future growth.

Management expressed satisfaction with the EPS performance despite not providing revenue figures.

They emphasized ongoing commitment to innovation and pipeline development.

Amgen Beats on EPS, Stock Down 1.4%

Key numbers

Management commentary

Amgen Inc.

More earnings this week

Amgen Beats on EPS, Stock Down 1.4%

Key numbers

Management commentary